human | Q5 |
P496 | ORCID iD | 0000-0003-2467-3683 |
P1153 | Scopus author ID | 7402708979 |
P734 | family name | Yuan | Q716212 |
Yuan | Q716212 | ||
Yuan | Q716212 | ||
P735 | given name | Yunfei | Q8061244 |
Yunfei | Q8061244 | ||
P106 | occupation | researcher | Q1650915 |
Q28292754 | A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma |
Q39949546 | A functional polymorphism in the miR-146a gene is associated with the risk for hepatocellular carcinoma. |
Q37353932 | A modified radiofrequency ablation approach for treating distant lymph node metastasis in two patients with late-stage cancer |
Q34147202 | A novel GSK-3 beta-C/EBP alpha-miR-122-insulin-like growth factor 1 receptor regulatory circuitry in human hepatocellular carcinoma |
Q47443711 | A novel functional polymorphism in the Cdc6 promoter is associated with the risk for hepatocellular carcinoma |
Q86822496 | A novel vascular pattern promotes metastasis of hepatocellular carcinoma in an epithelial-mesenchymal transition-independent manner |
Q41152266 | A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control study. |
Q36200984 | ANXA3/JNK Signaling Promotes Self-Renewal and Tumor Growth, and Its Blockade Provides a Therapeutic Target for Hepatocellular Carcinoma. |
Q39034955 | Allele-specific imbalance of oxidative stress-induced growth inhibitor 1 associates with progression of hepatocellular carcinoma. |
Q33711636 | Application of tumor-node-metastasis staging 2002 version in locally advanced hepatocellular carcinoma: is it predictive of surgical outcome? |
Q89535408 | Author response to Letter to the Editor: 'Are inflammation-based models feasible tools in predicting the outcome of patients with hepatocellular carcinoma?' |
Q37226458 | Bevacizumab with preoperative chemotherapy versus preoperative chemotherapy alone for colorectal cancer liver metastases: a retrospective cohort study |
Q33755370 | CHD1L promotes hepatocellular carcinoma progression and metastasis in mice and is associated with these processes in human patients. |
Q50518741 | CHD1L promotes lineage reversion of hepatocellular carcinoma through opening chromatin for key developmental transcription factors. |
Q36659343 | CHK1 targets spleen tyrosine kinase (L) for proteolysis in hepatocellular carcinoma. |
Q45366225 | Changes in hepatitis B virus DNA levels and liver function after transcatheter arterial chemoembolization of hepatocellular carcinoma. |
Q38314621 | Characterization of the oncogenic function of centromere protein F in hepatocellular carcinoma. |
Q87165954 | Checkpoint kinase 1 is negatively regulated by miR-497 in hepatocellular carcinoma |
Q87021317 | Clinical significance and prognostic value of microRNA expression signatures in hepatocellular carcinoma |
Q45371340 | Clinical significance of CHD1L in hepatocellular carcinoma and therapeutic potentials of virus-mediated CHD1L depletion. |
Q45702387 | Clinicopathologic features and long-term outcomes of Chinese patients with hepatocellular carcinoma in non-cirrhotic liver |
Q90943573 | Comparison of the prognostic value of inflammation-based scores in early recurrent hepatocellular carcinoma after hepatectomy |
Q40389253 | CpG Methylation Signature Predicts Recurrence in Early-Stage Hepatocellular Carcinoma: Results From a Multicenter Study |
Q54444216 | CpG island methylator phenotype associated with tumor recurrence in tumor-node-metastasis stage I hepatocellular carcinoma. |
Q120156331 | Dysregulation of PLOD2 Promotes Tumor Metastasis and Invasion in Hepatocellular Carcinoma |
Q45352662 | Effects of antiviral therapy on hepatitis B virus reactivation and liver function after resection or chemoembolization for hepatocellular carcinoma. |
Q86307530 | Efficacy and safety of thermal ablation in patients with liver metastases |
Q39358186 | Expression and prognostic significance of CIP2A mRNA in hepatocellular carcinoma and nontumoral liver tissues. |
Q37646934 | Expression of variant isoforms of the tyrosine kinase SYK determines the prognosis of hepatocellular carcinoma. |
Q43413375 | Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers |
Q85741755 | HBP21, a chaperone of heat shock protein 70, functions as a tumor suppressor in hepatocellular carcinoma |
Q86485800 | Hepatectomy Versus Hepatectomy With Lymphadenectomy in Hepatocellular Carcinoma: A Prospective, Randomized Controlled Clinical Trial |
Q45749941 | Hepatectomy for hepatocellular carcinoma patients with macronodular cirrhosis |
Q45383669 | Hepatic resection for synchronous hepatic metastasis from gastric cancer. |
Q40548381 | High preoperative serum CA19-9 level is predictive of poor prognosis for patients with colorectal liver oligometastases undergoing hepatic resection |
Q34561185 | Identification of medium-sized genomic deletions with low coverage, mate-paired restricted tags |
Q59799844 | Impact of follow-up interval on patients with hepatocellular carcinoma after curative ablation |
Q36121202 | Impact of oral anti-hepatitis B therapy on the survival of patients with hepatocellular carcinoma initially treated with chemoembolization |
Q33961542 | Interleukin 17A promotes hepatocellular carcinoma metastasis via NF-kB induced matrix metalloproteinases 2 and 9 expression. |
Q34438689 | Interleukin 23 promotes hepatocellular carcinoma metastasis via NF-kappa B induced matrix metalloproteinase 9 expression |
Q33812222 | LOH analysis of genes around D4S2964 identifies ARD1B as a prognostic predictor of hepatocellular carcinoma |
Q45399492 | Large-scale analysis of the genetic and epigenetic alterations in hepatocellular carcinoma from Southeast China. |
Q93387660 | Letter: is microwave ablation superior to radiofrequency ablation for early stage hepatocellular carcinoma? Authors' reply |
Q57455124 | Letter: microwave vs radiofrequency ablation for hepatocellular carcinoma within the Milan criteria-Authors' reply |
Q38719518 | Lidocaine Induces Apoptosis and Suppresses Tumor Growth in Human Hepatocellular Carcinoma Cells In Vitro and in a Xenograft Model In Vivo. |
Q93143861 | Lipiodol deposition in portal vein tumour thrombus predicts treatment outcome in HCC patients after transarterial chemoembolisation |
Q43240643 | Liver cancer: EphrinA2 promotes tumorigenicity through Rac1/Akt/NF-kappaB signaling pathway |
Q39365871 | Liver hypertrophy and accelerated growth of implanted tumors in nonembolized liver of rabbit after left portal vein embolization. |
Q88761252 | Long- versus short-interval follow-up after resection of hepatocellular carcinoma: a retrospective cohort study |
Q45010628 | Long-term outcomes and prognostic factors of elderly patients with hepatocellular carcinoma undergoing hepatectomy |
Q47869237 | Long-term survival after resection of hepatocelluar carcinoma: a potential risk associated with the choice of postoperative analgesia |
Q38861160 | Loss of ATOH8 Increases Stem Cell Features of Hepatocellular Carcinoma Cells |
Q34745477 | MACC1 as a prognostic biomarker for early-stage and AFP-normal hepatocellular carcinoma |
Q47821487 | Maelstrom promotes hepatocellular carcinoma metastasis by inducing epithelial-mesenchymal transition by way of Akt/GSK-3β/Snail signaling. |
Q39309630 | MicroRNA-125b promotes apoptosis by regulating the expression of Mcl-1, Bcl-w and IL-6R. |
Q54191926 | MicroRNA-130a is down-regulated in hepatocellular carcinoma and associates with poor prognosis. |
Q39184127 | MicroRNA-195 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting the expression of VEGF, VAV2, and CDC42. |
Q40536884 | MicroRNAs miR-125b and miR-100 suppress metastasis of hepatocellular carcinoma by disrupting the formation of vessels that encapsulate tumour clusters. |
Q90532946 | Microwave ablation versus resection for hepatocellular carcinoma within the Milan criteria: a propensity-score analysis |
Q90659238 | Microwave vs radiofrequency ablation for hepatocellular carcinoma within the Milan criteria: a propensity score analysis |
Q33702300 | Mutual Regulation of MiR-199a-5p and HIF-1α Modulates the Warburg Effect in Hepatocellular Carcinoma. |
Q39474147 | NADPH oxidase DUOX1 and DUOX2 but not NOX4 are independent predictors in hepatocellular carcinoma after hepatectomy. |
Q40775158 | Nomograms for Pre- and Postoperative Prediction of Long-term Survival for Patients Who Underwent Hepatectomy for Multiple Hepatocellular Carcinomas |
Q38503687 | Novel therapeutic potential in targeting microtubules by nanoparticle albumin-bound paclitaxel in hepatocellular carcinoma. |
Q48273193 | Octamer 4/microRNA-1246 signaling axis drives Wnt/β-catenin activation in liver cancer stem cells. |
Q97533883 | PIM2 promotes hepatocellular carcinoma tumorigenesis and progression through activating NF-κB signaling pathway |
Q34517592 | Partial hepatectomy for liver metastases from nasopharyngeal carcinoma: a comparative study and review of the literature |
Q53153527 | Percutaneous microwave ablation of larger hepatocellular carcinoma. |
Q85303207 | Phase I trial of hepatic arterial infusion (HAI) of floxuridine with modified oxaliplatin, 5-fluorouracil and leucovorin (m-FOLFOX6) in Chinese patients with unresectable liver metastases from colorectal cancer |
Q39635505 | Prognostic value of Wnt inhibitory factor-1 expression in hepatocellular carcinoma that is independent of gene methylation. |
Q71699166 | Randomized study of chemoembolization as an adjuvant therapy for primary liver carcinoma after hepatectomy |
Q45083949 | Reactivation of SYK expression by inhibition of DNA methylation suppresses breast cancer cell invasiveness |
Q41750292 | Resection versus ablation in hepatitis B virus-related hepatocellular carcinoma patients with portal hypertension: A propensity score matching study. |
Q53756810 | Response to Ablation and resection for hepatocellular carcinoma within the Milan criteria and high alpha-fetoprotein levels. |
Q39581200 | Role of Sox2 and Oct4 in predicting survival of hepatocellular carcinoma patients after hepatectomy. |
Q53263915 | SPOCK1 is regulated by CHD1L and blocks apoptosis and promotes HCC cell invasiveness and metastasis in mice. |
Q36916295 | Safety and efficacy of sorafenib therapy in patients with hepatocellular carcinoma: final outcome from the Chinese patient subset of the GIDEON study. |
Q39409326 | Serum and glucocorticoid kinase 3 at 8q13.1 promotes cell proliferation and survival in hepatocellular carcinoma. |
Q37701106 | Sorafenib therapy following resection prolongs disease-free survival in patients with advanced hepatocellular carcinoma at a high risk of recurrence |
Q27311589 | Systemic delivery of microRNA-101 potently inhibits hepatocellular carcinoma in vivo by repressing multiple targets |
Q36237549 | TGF-β-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma. |
Q33776697 | The Role of Adjuvant Chemotherapy for Colorectal Liver Metastasectomy after Pre-Operative Chemotherapy: Is the Treatment Worthwhile? |
Q39347890 | The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection. |
Q35441132 | The role of clinically significant portal hypertension in hepatic resection for hepatocellular carcinoma patients: a propensity score matching analysis |
Q95655738 | Transcatheter arterial chemoembolization alone or combined with ablation for recurrent intermediate-stage hepatocellular carcinoma: a propensity score matching study |
Q53216551 | Translationally controlled tumor protein induces mitotic defects and chromosome missegregation in hepatocellular carcinoma development. |
Q34667439 | Upregulation of microRNA-106b is associated with poor prognosis in hepatocellular carcinoma |
Search more.